Dimerization of the human neuropeptides oxytocin and vasopressin can produce new types of bioactive molecules. Such new constructs provide several opportunities to optimize the efficacy of these neuropeptides for therapeutic application. The researchers were inspired for this approach from naturally occurring dimers.